{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:48:22Z","timestamp":1793162902913,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.intimp.2024.111824","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T01:43:47Z","timestamp":1710121427000},"page":"111824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["A therapeutic strategy of parthenolide in improving imiquimod-induced psoriasis-like skin inflammation targeting IL-36\/NETs through skin transdermal therapeutic system"],"prefix":"10.1016","volume":"131","author":[{"given":"Zi-Ying","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Hui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6221-4309","authenticated-orcid":false,"given":"Ji-Xing","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Hua","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10281","key":"10.1016\/j.intimp.2024.111824_b0005","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.intimp.2024.111824_b0010","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jaad.2013.11.013","article-title":"Psoriasis prevalence among adults in the United States","volume":"70","author":"Rachakonda","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"issue":"19","key":"10.1016\/j.intimp.2024.111824_b0015","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"J. Am. Med. Assoc."},{"issue":"2","key":"10.1016\/j.intimp.2024.111824_b0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"9997","key":"10.1016\/j.intimp.2024.111824_b0025","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.intimp.2024.111824_b0030","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.molimm.2014.12.014","article-title":"Genetic and epigenetic basis of psoriasis pathogenesis","volume":"64","author":"Chandra","year":"2015","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.111824_b0035","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2024.111824_b0040","doi-asserted-by":"crossref","first-page":"e107904","DOI":"10.1371\/journal.pone.0107904","article-title":"Inhibition of inflammatory and proliferative responses of human keratinocytes exposed to the sesquiterpene lactones dehydrocostuslactone and costunolide","volume":"9","author":"Scarponi","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.intimp.2024.111824_b0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s10856-021-06558-y","article-title":"Nano intervention in topical delivery of corticosteroid for psoriasis and atopic dermatitis-a systematic review","volume":"32","author":"Shetty","year":"2021","journal-title":"J. Mater. Sci. - Mater. Med."},{"key":"10.1016\/j.intimp.2024.111824_b0050","doi-asserted-by":"crossref","unstructured":"M. Lebwohl, P.T. Ting, J.Y. Koo, Psoriasis treatment: traditional therapy, Ann Rheum Dis 64 Suppl 2 (2005) ii83-6.","DOI":"10.1136\/ard.2004.030791"},{"key":"10.1016\/j.intimp.2024.111824_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106045","article-title":"Acitretin inhibits IL-17A-induced IL-36 expression in keratinocytes by down-regulating IkappaBzeta","volume":"79","author":"Tu","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.111824_b0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jaci.2016.08.056","article-title":"IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis","volume":"140","author":"Johnston","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.111824_b0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cytogfr.2020.06.006","article-title":"IL-36 in chronic inflammation and cancer","volume":"55","author":"Neurath","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.intimp.2024.111824_b0070","unstructured":"M. Sehat, R. Talaei, E. Dadgostar, H. Nikoueinejad, H.J.I.j.o.a. Akbari, asthma,, immunology, Evaluating Serum Levels of IL-33, IL-36, IL-37 and Gene Expression of IL-37 in Patients with Psoriasis Vulgaris, 17(2) (2018) 179-187."},{"issue":"2","key":"10.1016\/j.intimp.2024.111824_b0075","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123390","article-title":"Disrupting the IL-36 and IL-23\/IL-17 loop underlies the efficacy of calcipotriol and corticosteroid therapy for psoriasis","volume":"4","author":"German","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.intimp.2024.111824_b0080","doi-asserted-by":"crossref","unstructured":"S.K. Mahil, M. Catapano, P. Di Meglio, N. Dand, H. Ahlfors, I.M. Carr, C.H. Smith, R.C. Trembath, M. Peakman, J.J.S.t.m. Wright, An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target, 9(411) (2017) eaan2514.","DOI":"10.1126\/scitranslmed.aan2514"},{"issue":"9","key":"10.1016\/j.intimp.2024.111824_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094344","article-title":"Exploring the role of IL-36 cytokines as a new target in psoriatic disease","volume":"22","author":"Iznardo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2024.111824_b0090","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12016-020-08804-7","article-title":"A review of neutrophil extracellular traps (NETs) in disease: potential anti-NETs therapeutics","volume":"61","author":"Mutua","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.intimp.2024.111824_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/2450569","article-title":"Role of neutrophils in psoriasis","volume":"2020","author":"Wang","year":"2020","journal-title":"J. Immunol. Res."},{"issue":"12","key":"10.1016\/j.intimp.2024.111824_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9121888","article-title":"Neutrophil extracellular traps in skin diseases","volume":"9","author":"Ogawa","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2024.111824_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00746","article-title":"Neutrophil extracellular traps promote inflammatory responses in psoriasis via activating epidermal TLR4\/IL-36R crosstalk","volume":"10","author":"Shao","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2024.111824_b0110","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1039\/C9NP00049F","article-title":"Advances in chemistry and bioactivity of parthenolide","volume":"37","author":"Freund","year":"2020","journal-title":"Nat. Prod. Rep."},{"issue":"9","key":"10.1016\/j.intimp.2024.111824_b0115","doi-asserted-by":"crossref","first-page":"15695","DOI":"10.1002\/jcb.28839","article-title":"Parthenolide regulates oxidative stress-induced mitophagy and suppresses apoptosis through p53 signaling pathway in C2C12 myoblasts","volume":"120","author":"Ren","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.intimp.2024.111824_b0120","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s10753-011-9346-0","article-title":"Parthenolide, a sesquiterpene lactone, expresses multiple anti-cancer and anti-inflammatory activities","volume":"35","author":"Mathema","year":"2012","journal-title":"Inflammation"},{"issue":"5","key":"10.1016\/j.intimp.2024.111824_b0125","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1039\/D2FO02545K","article-title":"Potential skin health promoting benefits of costunolide: a therapeutic strategy to improve skin inflammation in imiquimod-induced psoriasis","volume":"14","author":"Zhan","year":"2023","journal-title":"Food Funct."},{"issue":"6","key":"10.1016\/j.intimp.2024.111824_b0130","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/jid.2012.512","article-title":"IL-1R1 signaling facilitates Munro\u2019s microabscess formation in psoriasiform imiquimod-induced skin inflammation","volume":"133","author":"Uribe-Herranz","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.intimp.2024.111824_b0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76864-y","article-title":"Neutrophil extracellular traps are induced in a psoriasis model of interleukin-36 receptor antagonist-deficient mice","volume":"10","author":"Watanabe","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2024.111824_b0140","doi-asserted-by":"crossref","unstructured":"R.G.B. Langley, Psoriasis: epidemiology, clinical features, and quality of life, Annals of the Rheumatic Diseases 64(suppl_2) (2005) ii18-ii23.","DOI":"10.1136\/ard.2004.033217"},{"issue":"8","key":"10.1016\/j.intimp.2024.111824_b0145","doi-asserted-by":"crossref","DOI":"10.3390\/cells8080807","article-title":"Keratin 6, 16 and 17-critical barrier alarmin molecules in skin wounds and psoriasis","volume":"8","author":"Zhang","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.intimp.2024.111824_b0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40246-018-0158-2","article-title":"Mutational analysis of epidermal and hyperproliferative type I keratins in mild and moderate psoriasis vulgaris patients: a possible role in the pathogenesis of psoriasis along with disease severity","volume":"12","author":"Elango","year":"2018","journal-title":"Hum. Genomics"},{"issue":"21","key":"10.1016\/j.intimp.2024.111824_b0155","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1091\/mbc.e10-08-0703","article-title":"Novel function of keratins 5 and 14 in proliferation and differentiation of stratified epithelial cells","volume":"22","author":"Alam","year":"2011","journal-title":"Mol. Biol. Cell"},{"issue":"2","key":"10.1016\/j.intimp.2024.111824_b0160","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/med.21291","article-title":"Keratin 17: a critical player in the pathogenesis of psoriasis","volume":"34","author":"Jin","year":"2014","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.intimp.2024.111824_b0165","doi-asserted-by":"crossref","unstructured":"R.S. Stern, T. Nijsten, S.R. Feldman, D.J. Margolis, T.J.J.o.I.D.S.P. Rolstad, Psoriasis Is Common, Carries a Substantial Burden Even When Not Extensive, and Is Associated With Widespread Treatment Dissatisfaction, 9(2) (2004) 136-139.","DOI":"10.1046\/j.1087-0024.2003.09102.x"},{"issue":"2","key":"10.1016\/j.intimp.2024.111824_b0170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.smim.2016.04.003","article-title":"Neutrophil-derived chemokines on the road to immunity","volume":"28","author":"Tecchio","year":"2016","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.intimp.2024.111824_b0175","doi-asserted-by":"crossref","first-page":"9748345","DOI":"10.1155\/2017\/9748345","article-title":"Neutrophils: their role in innate and adaptive immunity 2017","volume":"2017","author":"Rosales","year":"2017","journal-title":"J. Immunol. Res."},{"issue":"4","key":"10.1016\/j.intimp.2024.111824_b0180","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/exd.13067","article-title":"Sexy again: the renaissance of neutrophils in psoriasis","volume":"26","author":"Schon","year":"2017","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.intimp.2024.111824_b0185","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.3389\/fimmu.2019.02376","article-title":"Neutrophils in psoriasis","volume":"10","author":"Chiang","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.111824_b0190","doi-asserted-by":"crossref","DOI":"10.1002\/cpim.16","article-title":"Induction and quantification of NETosis","volume":"115","author":"Carmona-Rivera","year":"2016","journal-title":"Curr. Protoc. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.111824_b0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-021-00491-3","article-title":"ROS induces NETosis by oxidizing DNA and initiating DNA repair","volume":"7","author":"Azzouz","year":"2021","journal-title":"Cell Death Discovery"},{"issue":"8","key":"10.1016\/j.intimp.2024.111824_b0200","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1038\/jid.2009.21","article-title":"Poly(I:C)-treated human langerhans cells promote the differentiation of CD4+ T cells producing IFN-\u03b3 and IL-10","volume":"129","author":"Furio","year":"2009","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.intimp.2024.111824_b0205","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/pr.110.002733","article-title":"Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases","volume":"62","author":"Korkmaz","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.intimp.2024.111824_b0210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.23.021704.115653","article-title":"How neutrophils kill microbes","volume":"23","author":"Segal","year":"2005","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2024.111824_b0215","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/2211-5463.12044","article-title":"Production of biologically active IL-36 family cytokines through insertion of N-terminal caspase cleavage motifs","volume":"6","author":"Clancy","year":"2016","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.intimp.2024.111824_b0220","doi-asserted-by":"crossref","unstructured":"J. Wolf, L.K.J.E.O.o.T.P. Ferris, Anti-IL-36R antibodies, potentially useful for the treatment of psoriasis: a patent evaluation of WO2013074569, 24(4) (2014) 477-9.","DOI":"10.1517\/13543776.2014.881473"},{"issue":"13","key":"10.1016\/j.intimp.2024.111824_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133318","article-title":"The significance of IL-36 hyperactivation and IL-36R targeting in psoriasis","volume":"20","author":"Madonna","year":"2019","journal-title":"Int. J. Mol. Sci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924003424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924003424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T06:43:39Z","timestamp":1731739419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924003424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":45,"alternative-id":["S1567576924003424"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111824","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A therapeutic strategy of parthenolide in improving imiquimod-induced psoriasis-like skin inflammation targeting IL-36\/NETs through skin transdermal therapeutic system","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111824","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111824"}}